NCT05251623: COPD

Walking Program With Pedometer on Quality of Life in COPD

Completed NA Last updated 23 February 2022

What this trial tests

NA trial testing walking program in Chronic Obstructive Pulmonary Disease in 45 participants. Completed in 31 March 2019.

Timeline

1 March 2018

Primary endpoint
31 March 2018

31 March 2019

Quick facts

Lead sponsor	Chang Gung University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	45
Start date	1 March 2018
Primary completion	31 March 2018
Estimated completion	31 March 2019
Sites	1 location across Taiwan

Drugs / interventions tested

• walking program

Conditions studied

• Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →

Sponsor

Chang Gung University

Who can join

40 and older, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the following measurements were performed: pulmonary function test (PFT), daily steps, Six-Minute Walk Test (6MWT), COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.